Pluri (PLUR) EBIT Growth (1y) (2011 - 2025)
Pluri (PLUR) EBIT Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
-31.25% |
| Date | Value |
|---|
| Dec 31, 2025 |
-31.25% |
| Sep 30, 2025 |
-22.16% |
| Jun 30, 2025 |
-9.73% |
| Mar 31, 2025 |
2.42% |
| Dec 31, 2024 |
4.91% |
| Sep 30, 2024 |
3.33% |
| Jun 30, 2024 |
7.79% |
| Mar 31, 2024 |
22.06% |
| Dec 31, 2023 |
21.95% |
| Sep 30, 2023 |
22.33% |
| Jun 30, 2023 |
26.32% |
| Mar 31, 2023 |
32.22% |
| Dec 31, 2022 |
38.13% |
| Sep 30, 2022 |
39.49% |
| Jun 30, 2022 |
39.11% |
| Mar 31, 2022 |
26.36% |
| Dec 31, 2021 |
17.43% |
| Sep 30, 2021 |
-30.95% |
| Jun 30, 2021 |
-71.33% |
| Mar 31, 2021 |
-92.26% |
